Holen Sie sich die Stockscreener-App
41.02
0.96%
0.39
Handel nachbörslich:
41.02
Schlusskurs vom Vortag:
$40.63
Offen:
$40.24
24-Stunden-Volumen:
243.64K
Relative Volume:
0.56
Marktkapitalisierung:
$1.94B
Einnahmen:
$384.90M
Nettoeinkommen (Verlust:
$-851.00K
KGV:
-2,051.00
EPS:
-0.02
Netto-Cashflow:
$12.83M
1W Leistung:
+1.26%
1M Leistung:
+0.79%
6M Leistung:
+77.35%
1J Leistung:
+56.56%
1-Tages-Spanne:
$40.24
$41.26
1-Wochen-Bereich:
$39.30
$41.30
52-Wochen-Spanne:
$21.97
$45.07
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Vergleichen Sie AORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
41.02 | 1.92B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-27 | Bestätigt | Lake Street | Buy |
| 2022-08-08 | Eingeleitet | Lake Street | Buy |
| 2022-03-03 | Eingeleitet | Stifel | Buy |
Alle ansehen
Artivion Inc Aktie (AORT) Neueste Nachrichten
What data driven models say about Artivion Inc.’s futureWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Will Artivion Inc. stock benefit from AI adoptionDividend Hike & Low Drawdown Trading Strategies - newser.com
How Investors Are Reacting To Artivion (AORT) Clinical Trial Results for Hybrid Aortic Dissection Device - Yahoo Finance
Artivion reports positive data from AMDS trials for aortic disease By Investing.com - Investing.com Nigeria
Risk adjusted return profile for Artivion Inc. analyzed2025 Technical Patterns & Risk Managed Investment Signals - newser.com
What catalysts could drive Artivion Inc. stock higherM&A Rumor & High Accuracy Swing Trade Signals - newser.com
Is Artivion Inc. stock safe for conservative investors2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Can Artivion Inc. hit a new high this monthOil Prices & AI Driven Price Forecasts - newser.com
Applying big data sentiment scoring on Artivion Inc.July 2025 Reactions & Short-Term High Return Strategies - newser.com
Artivion (AORT) Shows Promising Results from Key Cardiovascular Trials - GuruFocus
How sustainable is Artivion Inc. stock dividend payoutPortfolio Value Report & Weekly Momentum Picks - newser.com
Artivion reports positive data from AMDS trials for aortic disease - Investing.com India
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - PR Newswire
Stocks with Diverging Prospects: Snowflake a Buy, Mercury & Artivion a SellNews and Statistics - IndexBox
Candlestick signals on Artivion Inc. stock today2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Positive AMDS Clinical Results Might Change the Case for Investing in Artivion (AORT) - Sahm
Is Artivion Inc. (CYL) stock positioned for secular growthTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Artivion Inc.’s volatility index tracking explainedJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Artivion stock price target raised to $47 from $42 at Citizens - Investing.com Nigeria
Using data filters to optimize entry into Artivion Inc.Earnings Growth Summary & Community Verified Watchlist Alerts - newser.com
Trend analysis for Artivion Inc. this week2025 AllTime Highs & Consistent Return Investment Signals - newser.com
Custom watchlist performance reports with Artivion Inc.Weekly Stock Report & Technical Analysis for Trade Confirmation - newser.com
Has Artivion Inc. formed a bullish divergenceTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
Published on: 2025-10-09 03:33:28 - newser.com
How Artivion Inc. stock reacts to stronger dollarEarnings Recap Summary & Daily Entry Point Alerts - newser.com
Why analysts maintain buy rating on Artivion Inc. (CYL) stock2025 Analyst Calls & Detailed Earnings Play Strategies - newser.com
Artivion's (AORT) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
State of Alaska Department of Revenue Increases Holdings in Artivion, Inc. $AORT - Defense World
What drives Artivion Inc CYL stock priceSmall Cap Stock Opportunities & Free ETF and Mutual Fund Comparisons - earlytimes.in
Brokerages Set Artivion, Inc. (NYSE:AORT) PT at $43.13 - Defense World
Artivion Inc. stock retracement – recovery analysisQuarterly Profit Summary & Daily Volume Surge Signals - newser.com
How to use Fibonacci retracement on Artivion Inc.Portfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Understanding Artivion Inc.’s price movementEarnings Trend Report & High Accuracy Trade Alerts - newser.com
Why retail investors pile into Artivion Inc. stockWeekly Trade Analysis & Verified Swing Trading Watchlists - newser.com
Will Artivion Inc. stock keep raising dividendsMarket Movement Recap & Technical Confirmation Alerts - newser.com
What insider trading reveals about Artivion Inc. stockMarket Growth Summary & Precise Swing Trade Alerts - newser.com
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):